Menopause Symptoms

4

Review clinical trials related to Menopause Symptoms. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Dietary Supplements and Middle Aged Women (Creatine)

This study will examine the effects of combining different types of dietary supplements on various aspects of health and wellbeing in middle aged women. The main outcomes of the trial will be aspects of health and wellbeing that middle aged women report as increasingly problematic, such as joint pain, fatigue, sleep, and changes in body composition, strength, and inflammation. Participants will consume the supplement(s) or placebo for 8 weeks, and outcome measures will be assessed before and after supplementation.

Participants needed: 38
Trial details
Age: 35-65Biological sex: FemaleType: InterventionalSponsor: Loughborough UniversityUpdated: Jul 28, 2026Locations: 1
Eligibility criteria

Female [+5]

Currently have a musculoskeletal injury or diagnosed condition (CVD, osteoarthri... [+8]

Status: Recruiting

Exploration of the Effect of a Wheat Polar Lipid Complex on Vaginal Dryness in Healthy Postmenopausal Women

This study aims to explore the positive effect of a dietary supplement composed of wheat polar lipids on vaginal dryness in healthy postmenopausal women

Participants needed: 110
Trial details
Age: 45-65Biological sex: FemaleType: InterventionalSponsor: SeppicUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

Healthy woman, aged of 45 to 65 years (inclusive) [+6]

Use of systemic hormonal therapy within the past 3 months [+9]

Status: Recruiting

The Impact of Concurrent Training on Women Experiencing Symptoms of Menopause

The aim of this study is to examine the impact of a concurrent training exercise intervention on menopausal symptoms and key physical and mental health outcomes. The proposed study is powered based on a primary outcome of examining the change in menopausal symptoms using the MenQoL questionnaire. Participants (n=70) will be randomised to an intervention or control group. The intervention group will participate in a 12 week online (via zoom) concurrent training programme, consisting of three forty-five minute sessions (on non-consecutive days) per week that align with WHO exercise recommendations for adults and the control group will maintain their regular activity. The exercise classes will be delivered by qualified Sport \& Exercise Scientists and will consist of a combination of bodyweight and resistance band exercises. Each class will consist of a 5 minute warm up, 15 minutes of aerobic exercise, 20 minutes of resistance training, and a 5 minute cool-down. Both groups will engage in pre and post testing through questionnaires (GAD-7, Patient Health Questionnaire-9 (PHQ-9), Menopause-Specific Quality of Life Questionnaire (MENQOL), Body Appreciation (BAS-2)), Pittsburgh Sleep Quality Index Sleep, International physical activity questionnaire (IPAQ), Body image questionnaire (BAS-2) and physical tests (Bod pod, grip-strength, 3-RM leg press, 3-RM cable pull, counter-movement jump and Astrand Rhyming submaximal aerobic test).

Participants needed: 90
Trial details
Age: 40-60Biological sex: FemaleType: InterventionalSponsor: University College DublinUpdated: Feb 18, 2026Locations: 1
Eligibility criteria

Women experiencing perimenopause (irregular menstrual cycles of ≥7-day differenc... [+4]

BMI >35 and <18.5. [+8]

Status: Recruiting

Impact of Reducose® on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)

The purpose of this double-blind, randomized, placebo-controlled trial is to. evaluate daily Reducose® (mulberry leaf extract) supplementation taken with the two largest meals for 12 weeks on improving glycemic response and perimenopausal symptoms in women aged 40-60 years. Glycemic response is measured using Dexcom Stelo continuous glucose monitors during standardized test meals, and menopausal symptoms and sleep/quality-of-life outcomes are assessed using validated surveys administered through the Chloe app in a decentralized U.S. study.

Participants needed: 120
Trial details
Age: 40-60Biological sex: FemaleType: InterventionalSponsor: Phynova Group LtdUpdated: Jan 12, 2026Locations: 1
Eligibility criteria

Participants assigned female at birth (aged 40-60 years) will be recruited for t... [+14]

Participants assigned male at birth. [+25]